Compounding Pharmacy · Stafford, TX · 503A
Casa Pharma RX Review
Casa Pharma RX is a 503A licensed sterile compounding pharmacy in Stafford, Texas, operating a state-of-the-art cleanroom built to USP 797 and USP 800 standards. Sources APIs exclusively from FDA-registered suppliers. Its site describes patient-specific sterile compounding for licensed prescribers and does not name specific GLP-1 products or telehealth partners.
Casa Pharma RX names no GLP-1 products on its own site, but OnlineSemaglutide.org and Breeze Meds list it among their pharmacies. A cleanroom built to USP 797 meets a sterile-compounding standard; it is not an outside accreditation, and how PCAB accreditation works covers that difference.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Telehealth Providers Sourcing From This Pharmacy
These telehealth brands are reported to fulfill some or all compounded GLP-1 prescriptions through Casa Pharma RX. Sourcing arrangements can change over time.
RxSpan MD
Best for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Pallas Health
Best for: the most complete public disclosure of pharmacies and prescribing physicians we have found
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
OnlineSemaglutide.org
Best for: shoppers who want injection or tablet GLP-1 options at one dose-independent price
Editorial score · methodology
Certifications & Compliance
All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.
Drugs Produced
Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].
States Licensed (1)
Regulatory Actions
Weight Loss Rankings Score Breakdown
Scores are independently researched. See our methodology for details.
Medium confidence · Pharmacy details last verified November 2026 · How we verify provider data
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources & methodology (as of November 2026)
- 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
- 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
- 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
- 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.